Articles on Antiretroviral drugs
South Africa has the world's highest AIDS burden. Shutterstock
Adherence is delaying HIV elimination targets. What's needed to break the cycle
Michelle Moorhouse, University of the Witwatersrand and Willem Daniel Francois Venter, University of the Witwatersrand
Most of the reasons people don't take their medication aren't related to the antiretrovirals themselves, but rather social and systemic issues.
Access to affordable medical treatment can save lives. Shutterstock
Cancer drug pricing gets in the way of treatment in developing countries
Vikash Sewram, Stellenbosch University
The global cancer burden especially in developing countries is exacerbated by the high cost of treatment.
French President Emmanuel Macron has an HIV blood test as part of World AIDS Day observances Dec. 1, 2017. Charles Platiau/Reuters
AIDS treatment has progressed, but without a vaccine, suffering still abounds
Maureen Miller, Columbia University Medical Center
World AIDS Day is Dec. 1. With many advances in preventing and treating the disease, the disease has fallen from top of mind for many. An epidemiologist explains why that could be dangerous.
The largest number of HIV-exposed but uninfected children are in South Africa. Shutterstock
Babies born to mums with HIV face higher risks even though they're HIV negative
Amy Slogrove, Stellenbosch University; Kathleen M. Powis, Harvard Medical School , and Mary-Ann Davies, University of Cape Town
HIV negative children born to women with HIV have a greater risk of dying before their first birthday.
The WHO recommends HIV viral load testing to monitor people on ARVs. Shutterstock
How innovation can help end the AIDS epidemic by 2030
Glenda Gray, South African Medical Research Council
Introducing viral load testing at health facilities can help South Africa reach the United Nations target to end AIDS.
A girl gets tested for HIV in Uganda where attempts to integrate HIV services with general health service have failed. Shutterstock
Why integrating HIV with non-HIV services in Uganda won't work
Henry Zakumumpa, Makerere University
In Uganda stand-alone clinics for HIV treatment persist because of stigma and overcrowding.
A community health worker conducting a HIV test in a mobile clinic in a remote part of KwaZulu-Natal. Greg Lomas / Médecins Sans Frontières
Men aren't being tested for HIV. How health services can plug the gap
Dr Morna Cornell, University of Cape Town
Women and children remain the focus of HIV while men are disadvantaged in accessing testing and treatment in Africa.
More than 15 000 researchers, activists and policymakers descend on Amsterdam this week for the 22nd International Aids Conference. Marcus Rose/IAS
The HIV pandemic: time to recalibrate and target the weak spots
Linda-Gail Bekker, University of Cape Town
The HIV epidemic is far from over and it's not time to disengage, says International Aids Society President Linda-Gail Bekker.
How health workers have adapted to South Africa's breastfeeding policy
Sara Nieuwoudt, University of the Witwatersrand
Health workers promote exclusive breastfeeding to HIV positive mothers more than they do to mothers who are negative.
There needs to be a wide range of sexual health services for men who have sex with men. Shutterstock
Providing healthcare to men who have sex with men is complex but possible
Kate Rees, University of Cape Town and Remco Peters, University of Pretoria
In many parts of sub-Saharan Africa men who have sex with men encounter stigma and prejudice when accessing health services.
NIAID
One year in: lessons on rolling out an HIV prevention pill in South Africa
Sinead Delany-Moretlwe, University of the Witwatersrand and Saiqa Mullick, University of the Witwatersrand
South Africa's data rollout of its pre-exposure prophylaxis shows that there is a relatively slow, but increasing, uptake. However, more needs to be done to target young women.
Pillbox (illustration only). Shutterstock
Could we safely reduce the frequency of treatments for HIV-positive people?
Caroline Petit, École normale supérieure (ENS)
A clinical trial currently underway in France could confirm that that HIV treatment can be safely reduced to just four days a week, while maintaining the same efficacy.
Reuters/Rogan Ward
Why traditional healers could have a role to play in fighting HIV
Ryan G Wagner, University of the Witwatersrand and Carolyn Audet, Vanderbilt University
In rural areas where there are often fewer healthcare professionals available, traditional healers can have a role to play in promoting HIV treatment.
Four big insights into HIV/AIDS that provide hope of finding a vaccine
Thumbi Ndung'u, University of KwaZulu-Natal
To get an effective vaccine for HIV/AIDS, scientists need to understand exactly how the virus works and immune system responds to it. African scientists have come one step closer.
Three decades on, stigma still stymies HIV prevention and treatment
Stigma stops people from getting tested for HIV, and staying on their treatment. Unless it's addressed, the AIDS epidemic will persist.
Antiretroviral drugs suppress the HIV virus and stop progression of the disease. Reuters/Finbarr O'Reilly
Kenya embraces new prevention efforts to reduce HIV infection
Griffins Manguro, Ghent University
The introduction of Pre Exposure Prophylaxis drugs in Kenya aims at reducing new HIV infections among people facing substantial ongoing risk.
In the Democratic Republic of Congo, HIV is still highly stigmatised. MSF/Tommy Trenchard
HIV is still taboo in the DRC: chronicles from Kinshasa
Emilie Venables, University of Cape Town
HIV remains a synonym for death in Kinshasa and many leave testing and treatment until it's too late. It's not common knowledge that an infected person can live a normal and healthy life.
Activists supporting the decriminalisation of sex work at the 21st International AIDS Conference in Durban, South Africa. International AIDS Society/Abhi Indrarajan
A sex worker's view on South Africa's latest plans to beat HIV
Susann Huschke, University of the Witwatersrand
South Africa has launched a plan to tackle HIV, TB and sexually transmitted infections -- but much depends on its implementation over the next five years.
People with a certain gene have an adverse reaction to the antiretroviral efavirenz. Shutterstock
How a gene test can solve side effects linked to ARV drugs in Africa
Collen Masimirembwa, University of Cape Town
Up to 50% of the people who take the efavirenz antiretroviral react particularly badly to it and need to change drug regimens.
Zimbabweans living with HIV who come to South Africa often have challenges remaining on their antiretroviral treatment regimens. Henk Kruger
HIV has no borders, but its treatment does. Why this needs to change
Matthew Wilhelm-Solomon, University of the Witwatersrand
South Africa and Zimbabwe have made significant strides to roll out antiretrovirals. But the regional expansion of treatment programmes still needs work.
1 2 3 Last
Antiretroviral therapy
International Aids Conference 2016
pre-exposure prophylaxis
RandD
South African health
Bridget Haire
Postdoctoral Research Fellow, Kirby Institute, UNSW
Sharon Lewin
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
Lawrence O. Gostin
Professor of Global Health and Director, O'Neill Institute, Georgetown University
Glenda Gray
Research Professor, Perinatal HIV Research Unit and President, South African Medical Research Council
Sinead Delany-Moretlwe
Associate Professor and Director: Research at the Wits Reproductive Health and HIV Institute I, University of the Witwatersrand
Willem Daniel Francois Venter
Deputy Executive Director, Wits Reproductive Health and HIV Institute, University of the Witwatersrand
Saiqa Mullick
Director of Implementation Science, Wits Reproductive Health & HIV Institute, University of the Witwatersrand
Linda-Gail Bekker
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Scientia Professor of Medicine and Director, Kirby Institute, UNSW
Robert Booy
Professor and Head of Clinical Research, National Centre for Immunisation Research and Surveillance, University of Sydney
Jodie McVernon
Professor and Director of Doherty Epidemiology, University of Melbourne
Jennifer Power
Senior Research Fellow at the Australian Research Centre in Sex, Health and Society, La Trobe University
Nic Geard
Nic Geard is a Friend of The Conversation.
Senior Lecturer, School of Computing and Information Systems, University of Melbourne; Senior Research Fellow, Doherty Institute for Infection and Immunity, University of Melbourne
Cheryl Overs
Senior Research Fellow, Monash University
Rebecca Guy
Associate Professor of Epidemiology & Program Head of Surveillance Evaluation and Research, UNSW